Covered recipient · General Payments record
LESLIE L CITROME
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
Saved only in this browser. No account or alerts.
General Payments · PY2022 · Entire year
$860,237.49
736 records · 0 disputed
“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”
— Centers for Medicare & Medicaid Services, Open Payments
A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.
These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Methodology & Data — sourcing, labeling, and limitations.
Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗
By nature of payment
PY2022 · entire year · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $461,596.10 | 146 |
| Consulting Fee | $269,026.27 | 55 |
| Travel and Lodging | $97,970.31 | 311 |
| Honoraria | $17,666.00 | 7 |
| Food and Beverage | $13,978.81 | 217 |
By paying entity
PY2022 · entire year · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $181,076.92 | 156 |
| ABBVIE INC. | $143,986.08 | 100 |
| Alkermes, Inc. | $141,819.41 | 152 |
| Neurocrine BioSciences, Inc. | $122,266.78 | 100 |
| Otsuka America Pharmaceutical, Inc. | $71,445.33 | 101 |
| ITI, Inc. | $35,143.31 | 34 |
| IDORSIA PHARMACEUTICALS US INC | $27,123.09 | 20 |
| EISAI INC. | $27,000.00 | 3 |
| Janssen Pharmaceuticals, Inc | $19,163.49 | 18 |
| H. Lundbeck A S | $18,894.00 | 12 |
| ACADIA Pharmaceuticals Inc | $17,750.00 | 1 |
| Sunovion Pharmaceuticals Inc. | $14,621.72 | 6 |
| Neurelis, Inc. | $10,900.97 | 13 |
| Janssen Scientific Affairs, LLC | $6,510.00 | 2 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $6,480.00 | 3 |
| Boehringer Ingelheim International GmbH | $4,830.00 | 2 |
| Sage Therapeutics, Inc. | $4,165.50 | 6 |
| Eisai Co., Ltd. | $2,700.00 | 1 |
| Otsuka Pharmaceutical Co., Ltd. | $2,058.00 | 1 |
| Supernus Pharmaceuticals, Inc. | $1,546.34 | 2 |
| Noven Pharmaceuticals, Inc. | $650.00 | 1 |
| Biogen, Inc. | $72.10 | 1 |
| Axsome Therapeutics, Inc. | $34.45 | 1 |
Page 8 of 15; records 351–400 of 736 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.
IndustryPayments · General Payments
LESLIE L CITROME
NPI 1780796045 · CMS profile ID 171564
Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry
POMONA, NY
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types
Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00
Page 8 of 15; records 351–400 of 736 matching records. This page contains 50 records (maximum 50), not the full filtered export.
Filtered page: https://industrypayments.org/provider/npi-1780796045?year=2022&recipient=provider&page=8#records-h
CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c
Cite these filtered records
The citation includes this program year, filters, data edition, and page of results.
- Plain
- LESLIE L CITROME, NPI 1780796045, CMS profile ID 171564. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 8 of 15; records 351–400 of 736 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1780796045?year=2022&recipient=provider&page=8#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
- APA 7
- IndustryPayments. (2026). LESLIE L CITROME, NPI 1780796045, CMS profile ID 171564. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 8 of 15; records 351–400 of 736 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1780796045?year=2022&recipient=provider&page=8#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
- Bluebook
- LESLIE L CITROME, NPI 1780796045, CMS profile ID 171564, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 8 of 15; records 351–400 of 736 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1780796045?year=2022&recipient=provider&page=8#records-h.
Centers for Medicare & Medicaid Services, Open Payments
Citation formats are provided for reference; check the requirements of your publication.
Payment records · PY2022
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30
736 matching records · $860,237.49 reported total · 0 disputed
Nature of payment: All payment types
Records imported here (UTC).
CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.
Showing records 351–400 of 736.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Publication flags | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $111.04 | 07/21/2022 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 954418073 | CMS |
| Teva Pharmaceuticals USA, Inc. | $138.88 | 07/21/2022 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 954418075 | CMS |
| Teva Pharmaceuticals USA, Inc. | $33.28 | 07/21/2022 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 954418079 | CMS |
| EISAI INC. | $9,000.00 | 07/20/2022 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 908057551 | CMS |
| Otsuka America Pharmaceutical, Inc. | $193.61 | 07/20/2022 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 929274445 | CMS |
| Otsuka America Pharmaceutical, Inc. | $187.40 | 07/20/2022 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 929274447 | CMS |
| Otsuka America Pharmaceutical, Inc. | $93.00 | 07/20/2022 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 929274449 | CMS |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $810.00 | 07/18/2022 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 933755829 | CMS |
| Alkermes, Inc. | $146.65 | 07/15/2022 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 925828255 | CMS |
| Alkermes, Inc. | $136.89 | 07/15/2022 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 925828265 | CMS |
| Janssen Pharmaceuticals, Inc | $5,500.00 | 07/06/2022 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 886758897 | CMS |
| Alkermes, Inc. | $2,300.00 | 07/04/2022 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 925828079 | CMS |
| Alkermes, Inc. | $4,320.00 | 07/04/2022 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 925828081 | CMS |
| Neurocrine BioSciences, Inc. | $3,500.00 | 06/30/2022 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 963224067 | CMS |
| Neurocrine Biosciences, Inc. | $115.86 | 06/30/2022 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 963224061 | CMS |
| Neurocrine Biosciences, Inc. | $22.82 | 06/30/2022 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 963224065 | CMS |
| Teva Pharmaceuticals USA, Inc. | $5,313.00 | 06/29/2022 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 954417957 | CMS |
| Teva Pharmaceuticals USA, Inc. | $234.39 | 06/29/2022 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 954418147 | CMS |
| Teva Pharmaceuticals USA, Inc. | $597.46 | 06/29/2022 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 954418189 | CMS |
| Teva Pharmaceuticals USA, Inc. | $318.71 | 06/29/2022 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 954418199 | CMS |
| Alkermes, Inc. | $693.40 | 06/28/2022 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 925828075 | CMS |
| Alkermes, Inc. | $2,260.46 | 06/28/2022 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 925828077 | CMS |
| Alkermes, Inc. | $256.52 | 06/28/2022 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 925828083 | CMS |
| Alkermes, Inc. | $71.05 | 06/28/2022 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 925828137 | CMS |
| Alkermes, Inc. | $15.02 | 06/28/2022 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 925828139 | CMS |
| Teva Pharmaceuticals USA, Inc. | $1,250.00 | 06/24/2022 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 954417977 | CMS |
| ITI, Inc. | $2,675.00 | 06/23/2022 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 945668189 | CMS |
| ITI, Inc. | $871.86 | 06/23/2022 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 945668191 | CMS |
| ITI, Inc. | $138.89 | 06/23/2022 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 945668193 | CMS |
| Alkermes, Inc. | $3,300.00 | 06/22/2022 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 925828073 | CMS |
| Alkermes, Inc. | $324.90 | 06/22/2022 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 925828251 | CMS |
| Alkermes, Inc. | $628.56 | 06/22/2022 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 925828253 | CMS |
| Otsuka Pharmaceutical Co., Ltd. | $2,058.00 | 06/22/2022 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 873901955 | CMS |
| ABBVIE INC. | $95.70 | 06/21/2022 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 890764925 | CMS |
| ABBVIE INC. | $4,375.00 | 06/21/2022 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 890764927 | CMS |
| ABBVIE INC. | $397.19 | 06/21/2022 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 890764929 | CMS |
| ABBVIE INC. | $5.00 | 06/21/2022 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 890764931 | CMS |
| ABBVIE INC. | $4,375.00 | 06/21/2022 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 890764933 | CMS |
| ABBVIE INC. | $562.45 | 06/21/2022 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 890764935 | CMS |
| ABBVIE INC. | $3,125.00 | 06/21/2022 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 890764937 | CMS |
| ABBVIE INC. | $5.00 | 06/21/2022 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 890764939 | CMS |
| ABBVIE INC. | $95.70 | 06/21/2022 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 890764941 | CMS |
| ABBVIE INC. | $6.00 | 06/21/2022 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 890764943 | CMS |
| ABBVIE INC. | $19.94 | 06/21/2022 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 890764945 | CMS |
| ABBVIE INC. | $89.20 | 06/21/2022 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 890764947 | CMS |
| ABBVIE INC. | $922.93 | 06/21/2022 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 890764949 | CMS |
| ABBVIE INC. | $327.18 | 06/21/2022 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 890764951 | CMS |
| ABBVIE INC. | $20.00 | 06/21/2022 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 890764953 | CMS |
| Teva Pharmaceuticals USA, Inc. | $3,308.00 | 06/21/2022 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 954417995 | CMS |
| Neurocrine BioSciences, Inc. | $3,500.00 | 06/20/2022 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 963224059 | CMS |
By program year
All program years on this page · sorted by year
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.
Research Payments
One row per program year and role, newest year first · amounts for the two roles are never added together
| Program year | Role | Amount | Records |
|---|---|---|---|
| PY2025 | Recipient | $3,150.00 | 4 |
| PY2024 | Recipient | $11,970.00 | 1 |
| PY2023 | Recipient | $6,562.50 | 2 |
| PY2021 | Recipient | $1,050.00 | 1 |
| PY2020 | Recipient | $8,750.00 | 4 |
| PY2019 | Recipient | $4,550.00 | 2 |
Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.
Research Payments records · PY2025
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
4 records in PY2025
| Role | Paying entity | Amount | Date | Recipient | Study | Dispute status | Published | Record ID |
|---|---|---|---|---|---|---|---|---|
| Recipient | Boehringer Ingelheim International GmbH | $787.50 | 03/13/2025 | Covered Recipient Physician | A phase III randomized, double-blind, placebo-controlled parallel group trial to examine the efficacy and safety of Iclepertin once daily over 26 week treatment period in patients with schizophrenia (CONNEX-1) | No dispute reported | 06/30/2026 | 1220621860 |
| Recipient | Boehringer Ingelheim International GmbH | $787.50 | 03/13/2025 | Covered Recipient Physician | A phase III randomized, double-blind, placebo-controlled, parallel group trial to examine the efficacy and safety of Iclepertin once daily over 26 week treatment period in patients with schizophrenia (CONNEX-2) | No dispute reported | 06/30/2026 | 1220621862 |
| Recipient | Boehringer Ingelheim International GmbH | $787.50 | 03/13/2025 | Covered Recipient Physician | A phase III randomized, double-blind, placebo-controlled parallel group trial to examine the efficacy and safety of Iclepertin once daily over 26 week treatment period in patients with schizophrenia (CONNEX-3) | No dispute reported | 06/30/2026 | 1220621864 |
| Recipient | Boehringer Ingelheim International GmbH | $787.50 | 03/13/2025 | Covered Recipient Physician | An open label, single arm, extension trial to examine long-term safety of BI 425809 once daily in patients with schizophrenia who have completed previous BI 425809 Phase III trials.(CONNEX-X) | No dispute reported | 06/30/2026 | 1220621866 |